On June 3rd, 2018 The DASH DAO funded Medicinal Genomics to finally crack the cannabis genome. Medicinal Genomics was the first company to sequence the cannabis genome in 2011 but the sequencing technology of that era was not capable of getting the genome to the standard set by the Human Genome Project in 2001. Fast forward to 2018 and Pacific Biosciences now has tools that can sequence 20,000-100,000 base pair reads with single molecule sequencing.

In this video, Kevin McKernan explains that several unique findings are already emerging from the project. We now know that CBDA Synthase and THCA Synthase are about 300kb apart and now exist on the same contig emersed in segmental duplications of other broken synthase genes. This could mean the two genes interact with each other.

Kevin will share all this information and more at CannMed 2018 (October 22-24 at the UCLA Luskin Conference Center). Buy your tickets today at www.cannmedevents.com